Info: Read More
  • 中药标准品生产商,产品定制服务
  • 胡黄连苷I

    Picroside I

    胡黄连苷I
    产品编号 CFN99565
    CAS编号 27409-30-9
    分子式 = 分子量 C24H28O11 = 492.47
    产品纯度 >=98%
    物理属性 White powder
    化合物类型 Iridoids
    植物来源 The roots of Picrorhiza scrophulariiflora
    ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用
    提供自定义包装
    产品名称 产品编号 CAS编号 包装 QQ客服
    胡黄连苷I CFN99565 27409-30-9 10mg QQ客服:2159513211
    胡黄连苷I CFN99565 27409-30-9 20mg QQ客服:2159513211
    胡黄连苷I CFN99565 27409-30-9 50mg QQ客服:2159513211
    胡黄连苷I CFN99565 27409-30-9 100mg QQ客服:2159513211
    存储与注意事项
    1. 在您收到产品后请检查产品。如无问题,请将产品存入冰霜并且样品瓶保持密封,产品可以存放长达24个月(2-8摄氏度)。

    2. 只要有可能,产品溶解后,您应该在同一天应用于您的实验。 但是,如果您需要提前做预实验,或者需要全部溶解,我们建议您将溶液以等分试样的形式存放在-20℃的密封小瓶中。 通常,这些可用于长达两周。 使用前,打开样品瓶前,我们建议您将产品平衡至室温至少1小时。

    3. 需要更多关于溶解度,使用和处理的建议? 请发送电子邮件至:service@chemfaces.com
    订购流程
  • 1. 在线订购
  • 请联系我们QQ客服

  • 2. 电话订购
  • 请拨打电话:
    027-84237683 或 027-84237783

  • 3. 邮件或传真订购
  • 发送电子邮件到: manager@chemfaces.com 或
    发送传真到:027-84254680

  • 提供订购信息
  • 为了方便客户的订购,请需要订购ChemFaces产品的客户,在下单的时候请提供下列信息,以供我们快速为您建立发货信息。
  •  
  • 1. 产品编号(CAS No.或产品名称)
  • 2. 发货地址
  • 3. 联系方法 (联系人,电话)
  • 4. 开票抬头 (如果需要发票的客户)
  • 5. 发票地址(发货地址与发票地址不同)
  • 发货时间
    1. 付款方式为100%预付款客户,我们将在确认收到货款后当天或1-3个工作日发货。

    2. 付款方式为月结的客户,我们承诺在收到订单后当天或1-3个工作日内发货。

    3. 如果客户所需要的产品,需要重新生产,我们有权告知客户,交货时间需要延期。
    ChemFaces的产品在许多优秀和顶级科学期刊中被引用

    Cell. 2018 Jan 11;172(1-2):249-261.e12.
    doi: 10.1016/j.cell.2017.12.019.
    IF=36.216(2019)

    PMID: 29328914

    Cell Metab. 2020 Mar 3;31(3):534-548.e5.
    doi: 10.1016/j.cmet.2020.01.002.
    IF=22.415(2019)

    PMID: 32004475

    Mol Cell. 2017 Nov 16;68(4):673-685.e6.
    doi: 10.1016/j.molcel.2017.10.022.
    IF=14.548(2019)

    PMID: 29149595

    ACS Nano. 2018 Apr 24;12(4): 3385-3396.
    doi: 10.1021/acsnano.7b08969.
    IF=13.903(2019)

    PMID: 29553709

    Nature Plants. 2016 Dec 22;3: 16206.
    doi: 10.1038/nplants.2016.205.
    IF=13.297(2019)

    PMID: 28005066

    Sci Adv. 2018 Oct 24;4(10): eaat6994.
    doi: 10.1126/sciadv.aat6994.
    IF=12.804(2019)

    PMID: 30417089
    我们的产品现已经出口到下面的研究机构与大学,并且还在增涨
  • Georgia Institute of Technology (USA)
  • Mahatma Gandhi University (India)
  • FORTH-IMBB (Greece)
  • Center for protein Engineering (CIP) (Belgium)
  • Universiti Malaysia Pahang (Malaysia)
  • The Australian National University (Australia)
  • Institute of Tropical Disease Universitas Airlangga (Indonesia)
  • Korea Institute of Oriental Medicine (Korea)
  • Sapienza University of Rome (Italy)
  • Institute of Pathophysiology Medical University of Vienna (Austria)
  • St. Jude Children Research Hospital (USA)
  • University of Cincinnati (USA)
  • Universidade do Porto (Portugal)
  • Deutsches Krebsforschungszentrum (Germany)
  • More...
  • 国外学术期刊发表的引用ChemFaces产品的部分文献
  • Eur J Neurosci.2021, 53(11):3548-3560.
  • J Korean Med Ophthalmol Otolaryngol Dermatol2023, 36(1):21-39.
  • BioResources J.2020, 15(3).
  • Evid Based Complement Alternat Med.2022, 9767292,2.
  • J Agric Food Chem.2018, 66(1):351-358
  • J Ethnopharmacol.2017, 198:87-90
  • J Med Food.2019, 22(10):1067-1077
  • Heliyon.2023, 9(11):e21944.
  • J of L. Chroma.&Related Tech2017, 252-258
  • Molecules.2019, 24(23):E4303
  • Analytical methods2019, 11(6)
  • Evid Based Complement Alternat Med.2020, 2020:1970349.
  • Malaysian Journal of Analytical Sciences2022, 26(2):360-369.
  • Mol Cell.2017, 68(4):673-685
  • Int J Mol Sci.2021, 22(16):8604.
  • Ajou University2024, 4688116
  • Institut Pasteur Korea2020, doi: 10.21203.
  • Chem Biol Interact.2024, 394:110995.
  • Plants.2024, 13(10):1348;
  • Pharm Biol.2022, 60(1):2040-2048.
  • Nutrients.2018, 10(12):E1998
  • Evid Based Complement Alternat Med.2016, 2016:1739760
  • Plant Sci.2021, 313:111069.
  • ...
  • 生物活性
    Description: Picroside I is a hepatoprotective agent which is reported to be antimicrobial and used against hepatitis B. It has antioxidant, and anti-inflammatory activities, it may be the valuable anti-invasive drug candidates for cancer therapy by suppressing Collagenases and Gelatinases. Picroside I can enhance basic fibroblast growth factor(bFGF)-, staurosporine- or dbc-mitogen-activated protein (MAP)-induced neurite outgrowth from PC12D cells.
    Targets: cAMP | MAPK | MMP(e.g.TIMP)
    In vitro:
    Life Sci. 2002 Aug 30;71(15):1821-35.
    Picrosides I and II, selective enhancers of the mitogen-activated protein kinase-dependent signaling pathway in the action of neuritogenic substances on PC12D cells.[Pubmed: 12151059]

    METHODS AND RESULTS:
    Picroside I and Picroside II caused a concentration-dependent (> 0.1 microM) enhancement of basic fibroblast growth factor (bFGF, 2 ng/ml)-, staurosporine (10 nM)- and dibutyryl cyclic AMP (dbcAMP, 0.3 mM)-induced neurite outgrowth from PC12D cells. Furthermore, picrosides-induced enhancements of the bFGF-action were markedly inhibited by GF109203X (0.1 microM), a protein kinase C inhibitor. The expression of phosphorylated MAP kinase was markedly increased by bFGF (2 ng/ml) and dbcAMP (0.3 mM), whereas that was not enhanced by staurosporine (10 nM). Picrosides had no effect on the phosphorylation of MAP kinase induced by bFGF or dbcAMP and also unaffected it in the presence of staurosporine. These results suggest that Picroside I and Picroside II enhance bFGF-, staurosporine- or dbcAMP-induced neurite outgrowth from PC12D cells, probably by amplifying a down-stream step of MAP kinase in the intracellular MAP kinase-dependent signaling pathway.
    CONCLUSIONS:
    Picroside I and Picroside II may become selective pharmacological tools for studying the MAP kinase-dependent signaling pathway in outgrowth of neurites induced by many kinds of neuritogenic substances including bFGF.
    Pharmacognosy Res . 2017 Dec;9(Suppl 1):S53-S56.
    Picroside I and Picroside II from Tissue Cultures of Picrorhiza kurroa[Pubmed: 29333043]
    Abstract Background: Picrorhiza kurroa (PK) belongs to Scrophulariaceae family and is a representative endemic, medicinal herb, widely distributed throughout the higher altitudes of alpine Himalayas from west to east, between 3000 and 4500 m above mean sea level. Objective: The objective of the present study is to assess the production of picroside I and picroside II from tissue cultures of PK. Materials and methods: Auxiliary shoot tips of PK were incubated in Murashige and Skoog medium supplemented with indole-3-butyric acid and kinetin phytohormones. The callus produced was collected at different time intervals and was processed for extraction of picroside I and picroside II followed by thin layer chromatography and high-performance liquid chromatography HPLC analysis. Results: The maximum growth index was found to be 5.109 ± 0.159 at 16-week-old callus culture. The estimation of picroside-I and picroside-II was carried out by (HPLC) analysis; quantity of secondary metabolite found to be 16.37 ± 0.0007 mg/g for PK-I and 6.34 ± 0.0012 mg/g for PK-II. Conclusion: This is the first attempt to produce the Picroside-I and II in large amount by the tissue culture technique. It can be observed that the method of callus culture can be used in production of secondary metabolites Picroside-I and II from PK. Summary: Picrorhiza kurroa is a high value medicinal herb due to rich source of hepatoprotective metabolites, Picroside-I and Picroside-II. The medicinal importance of P. kurroa is due to its pharmacological properties like hepatoprotective, antioxidant (particularly in liver), antiallergic and antiasthamatic, anticancer activity particularly in liver and immunomodulatory. Shoot apices which were produced a good response was inoculated on selected medium i.e., on MS medium containing 2, 4 D (mg/l) + KN (1mg/l) for induction of callus. The initiation of callus was observed after 4weeks and it was light green and fragile Maximum growth was observed with 3% w/v of sucrose supplement. The callus culture was maintained and growth index was recorded after every subculture. The growth index was calculated from the obtained final dried weight divided by initial weight.Abbreviations Used: PK-Picrorhizakurroa, IBA-Indole-3-butyricacid, KN-Kinetin, 2,4D-2,4Dichlorophenoxy acetic acid. Keywords: Picrorhiza kurroa; picroside I; picroside II; tissue cultures.
    In vivo:
    Phytother. Res., 1993, 7(6):402-7.
    Antiinflammatory activity of the iridoids kutkin, picroside-1 and kutkoside from Picrorhiza kurrooa[Reference: WebLink]
    Powdered roots of Picrorhiza kurrooa (PK), its alcoholic extract (AEPK) and active constituents kutkin, Picroside I and kutkoside demonstrated antiinflammatory activity (AIA) in a variety of test models. Significant AIA was recorded in adjuvant-induced and formaldehyde arthritis in rats and mice. In carrageenan-induced oedema inhibitory activity was remarkably enhanced upon intraperitoneal treatment in rats and mice. Kutkin exhibited significant action in dextran-induced oedema in rats. It inhibited acetic acid induced vascular permeability in mice and leucocyte migration in rats. Kutkin lacked any analgesic, antipyretic or ulcerogenic effect.
    制备储备液(仅供参考)
    1 mg 5 mg 10 mg 20 mg 25 mg
    1 mM 2.0306 mL 10.1529 mL 20.3058 mL 40.6116 mL 50.7645 mL
    5 mM 0.4061 mL 2.0306 mL 4.0612 mL 8.1223 mL 10.1529 mL
    10 mM 0.2031 mL 1.0153 mL 2.0306 mL 4.0612 mL 5.0765 mL
    50 mM 0.0406 mL 0.2031 mL 0.4061 mL 0.8122 mL 1.0153 mL
    100 mM 0.0203 mL 0.1015 mL 0.2031 mL 0.4061 mL 0.5076 mL
    * Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
    部分图片展示
    产品名称 产品编号 CAS编号 分子式 = 分子量 位单 联系QQ
    6-O-肉桂酰梓醇; 6-O-Cinnamoylcatalpol CFN99428 136807-41-5 C24H28O11 = 492.5 5mg QQ客服:2159513211
    胡黄连苷I; Picroside I CFN99565 27409-30-9 C24H28O11 = 492.47 20mg QQ客服:1457312923
    黄金树苷; Specioside CFN97207 72514-90-0 C24H28O12 = 508.5 5mg QQ客服:3257982914
    6-O-对甲氧基肉桂酰梓醇; 6-O-p-Methoxycinnamoylcatalpol CFN99335 121710-02-9 C25H30O12 = 522.5 5mg QQ客服:2056216494
    梓醇6-咖啡酸酯; Verminoside CFN98809 50932-19-9 C24H28O13 = 524.5 5mg QQ客服:2056216494
    6-阿魏酰梓醇; 6-Feruloylcatalpol CFN97255 770721-33-0 C25H30O13 = 538.5 5mg QQ客服:1413575084
    米内苷; Minecoside CFN98811 51005-44-8 C25H30O13 = 538.5 20mg QQ客服:1457312923
    6-O-(3'',4''-二甲氧基肉桂酰)梓醇; 6-O-(3'',4''-Dimethoxycinnamoyl)catalpol CFN99611 147714-71-4 C26H32O13 = 552.5 5mg QQ客服:1413575084
    胡黄连苷IV; Picroside IV CFN90868 211567-04-3 C24H28O12 = 508.50 10mg QQ客服:3257982914
    胡黄连苷III; Picroside III CFN99567 64461-95-6 C25H30O13 = 538.50 20mg QQ客服:1457312923

    信息支持


    公司简介
    订购流程
    付款方式
    退换货政策

    ChemFaces提供的产品仅用于科学研究使用,不用于诊断或治疗程序。

    联系方式


    电机:027-84237783
    传真:027-84254680
    在线QQ: 1413575084
    E-Mail:manager@chemfaces.com

    湖北省武汉沌口经济技术开区车城南路83号1号楼第三层厂房


    ChemFaces为科学家,科研人员与企业提供快速的产品递送。我们通过瑞士SGS ISO 9001:2008质量体系认证天然化合物与对照品的研发和生产